Follow
Biotherapeutics
Biotherapeutics: Biotherapeutic products derived from recombinant DNA technology such as interferons, interleukins, and growth factors have provided a major advance in the safety and effectiveness of therapeutic peptides and proteins, and they have a successful record in treating many life-threatening and chronic diseases. Since contamination with unwanted pathogens can be greatly reduced and production volumes are expanded by the developed biotechnology, many more patients have increased access to biotherapeutic products. Technical issues such as the potential immunogenicity of active substances produced under differing manufacturing conditions must also be considered.
APR 08, 2020 | 12:00 AM
The NIST Biomanufacturing Program develops measurement science, standards, reference data and tools to support the development, manufacturing, and regulatory approval of biologic medicines....
APR 07, 2020 | 8:00 AM
DATE: April 7, 2020 TIME: 8:00am PT, 11:00am ET This webinar sets out to establish why quality control is key to robust, reliable, reproducible science. We will look at best practice criteri...
DEC 10, 2019 | 7:00 AM
DATE: December 11, 2019 TIME: 7:00am PST, 10:00am EST Rapid growth in the cell and gene therapy industry has generated an urgent need for robust analytics around characterization of both vec...
OCT 24, 2019 | 1:30 PM
With annual sales exceeding $145 billion, growth of biologic therapeutics is outpacing that of small-molecule drugs, and the development, manufacture, and delivery of biologics presents very...
OCT 24, 2019 | 9:00 AM
Therapeutic monoclonal antibodies are a clinically important and life-saving class of biotherapeutics used in the treatment of several previously intractable diseases. However, their developm...
OCT 22, 2019 | 9:00 AM
DATE: October 22, 2019 TIME: 9:00am PDT, 12:00PM EDT...
SEP 17, 2019 | 6:00 AM
DATE: September 17, 2019TIME: 6:00 am PDT, 9:00am EDT, 2:00pm BST, 3:00pm CEST Abstract: Learning Objectives: one two Webina...
AUG 29, 2019 | 9:00 AM
DATE: August 29, 2019TIME: 9:00am PT/ 12:00pm ET Monoclonal antibodies (mAbs) are a cornerstone of modern biomedical research and biotherapeutics. Therefore, reproducibly obtai...
AUG 14, 2019 | 9:00 AM
DATE: August 14, 2019TIME: 9:00am PT. 12:00pm ET Implementation of Lean Methodology in Biobanking Operations to standardize sample management processes is effective. Each proce...
JUL 30, 2019 | 6:00 AM
DATE: July 30, 2019TIME: 6:00am PT, 9:00am ET The current version of the EMA Guideline for the environmental risk assessment of human drugs was published in 2006. This guidance...
MAR 26, 2019 | 10:00 AM
DATE: March 26, 2019TIME: 10:00am PDT, 1:00pm EDT Despite being the most common autoimmune disorder in the United States, knowledge surrounding thyroid di...
FEB 28, 2019 | 7:00 AM
DATE: February 28, 2019TIME: 7:00 AM PST, 10:00 AM EST This presentation will cover the basic ELISA assay formats as well as ELISA-like assay f...
JAN 31, 2019 | 1:30 PM
Development of novel types of therapeutics require adaptation of traditional bioprocessing applications to include the use of primary cells, such as stem cells, fibroblasts, astrocytes and ne...
JAN 31, 2019 | 12:00 PM
As the pace of biotherapeutic approvals increases, so does the pressure on makers of new biologics to complete their development processes faster and more efficiently. The success of the drug...
JAN 31, 2019 | 10:30 AM
The Strep-Tactin®XT:Twin-Strep-tag®-purification system enables protein purification at high yields and purity under physiological conditions. Providing the highest binding affinity a...
JAN 31, 2019 | 10:30 AM
Multi-mode chromatography has come to prominence in recent years due to the general utility of multi-mode ligands for product capture and polishing. In particular, their application in flow-t...
